TR200000310T2 - Bir 3-(2-değiştirilmiş-vinil)-sefalosporin' in z-izomeri' nin seçici üretimine mahsus bir yöntem. - Google Patents

Bir 3-(2-değiştirilmiş-vinil)-sefalosporin' in z-izomeri' nin seçici üretimine mahsus bir yöntem.

Info

Publication number
TR200000310T2
TR200000310T2 TR2000/00310T TR200000310T TR200000310T2 TR 200000310 T2 TR200000310 T2 TR 200000310T2 TR 2000/00310 T TR2000/00310 T TR 2000/00310T TR 200000310 T TR200000310 T TR 200000310T TR 200000310 T2 TR200000310 T2 TR 200000310T2
Authority
TR
Turkey
Prior art keywords
isomer
cephalosporin
vinyl
modified
selective production
Prior art date
Application number
TR2000/00310T
Other languages
English (en)
Inventor
Okada Yumiko
Sukegawa Masamichi
Watanabe Tatsuo
Iwasawa Hiroyuki
Murai Yasushi
Iinuwa Katsuharu
Original Assignee
Meiji Seika Kaisha, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha, Ltd. filed Critical Meiji Seika Kaisha, Ltd.
Publication of TR200000310T2 publication Critical patent/TR200000310T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Asagidaki genel formül (IV)' e Formül (IV) ki burada, R1, bir hidrojen atomu'nu ya da bir tek-degerli amino-koruyan grubu göstermektedir, ya da, bir 2-(2-N-korunmus ya da korunmamis aminotiyazol-4-yl)-2-alkoksiiminoasetil grubu'nu göstermektedir, R2, bir hidrojen atomu'nu göstermektedir. Bu bulusun yöntemlerine göre, bilesik (IV) ' ün, Z-,izomeri' ninkinden, daha düsük anti bakteriyel tesirdeki türden olan E-izomeri' nin üretilmesi, fark edilir ölçüde önlenebilmektedir. Ilaveten, yüksek bir safliktaki Z-izomeri, etkin bir biçimde basit bir yoldan üretilebilmektedir.
TR2000/00310T 1997-06-24 1998-06-24 Bir 3-(2-değiştirilmiş-vinil)-sefalosporin' in z-izomeri' nin seçici üretimine mahsus bir yöntem. TR200000310T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16694897 1997-06-24

Publications (1)

Publication Number Publication Date
TR200000310T2 true TR200000310T2 (tr) 2000-08-21

Family

ID=15840609

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00310T TR200000310T2 (tr) 1997-06-24 1998-06-24 Bir 3-(2-değiştirilmiş-vinil)-sefalosporin' in z-izomeri' nin seçici üretimine mahsus bir yöntem.

Country Status (24)

Country Link
US (1) US6288223B1 (tr)
EP (1) EP1016665B1 (tr)
JP (1) JP3713282B2 (tr)
KR (1) KR100515273B1 (tr)
CN (1) CN1107679C (tr)
AT (1) ATE221890T1 (tr)
AU (1) AU731265B2 (tr)
BR (1) BR9810313B1 (tr)
CA (1) CA2294178C (tr)
CZ (1) CZ295599B6 (tr)
DE (1) DE69807093T2 (tr)
EA (1) EA002449B1 (tr)
ES (1) ES2182330T3 (tr)
HU (1) HU228767B1 (tr)
ID (1) ID24210A (tr)
IL (1) IL133681A (tr)
NZ (1) NZ502234A (tr)
PL (1) PL193367B1 (tr)
PT (1) PT1016665E (tr)
RO (1) RO120261B1 (tr)
SK (1) SK283525B6 (tr)
TR (1) TR200000310T2 (tr)
UA (1) UA55463C2 (tr)
WO (1) WO1998058932A1 (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4157177B2 (ja) * 1997-06-04 2008-09-24 大塚化学ホールディングス株式会社 ３−アルケニルセフェム化合物の製造法
WO2005003141A2 (en) * 2003-07-04 2005-01-13 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of cefditoren
EP1660505A2 (en) * 2003-08-14 2006-05-31 Ranbaxy Laboratories Limited Process for selective preparation of z-isomer of cefditoren and pharmaceutically acceptable salts and esters thereof
WO2005100369A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited Depletion of e-isomers in preparation of z-enriched 3-(2-substituted vinyl) cephalosporins
WO2005100367A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited Intermediates useful in the synthesis of 3-(2-substituted vinyl) cephalosporins
JP4046708B2 (ja) * 2004-06-04 2008-02-13 明治製菓株式会社 ３−アルケニルセフェム化合物の製造方法
JP4064948B2 (ja) * 2004-06-04 2008-03-19 明治製菓株式会社 ３−アルケニルセフェム化合物及び製造方法
TW200619222A (en) * 2004-09-02 2006-06-16 Rohm & Haas Elect Mat Method for making organometallic compounds
JP2006096679A (ja) * 2004-09-28 2006-04-13 Meiji Seika Kaisha Ltd セファロスポリン化合物の製造方法
CN101665499A (zh) * 2008-09-01 2010-03-10 日本化学工业株式会社 头孢烯化合物的制造方法
EP2520578A1 (en) 2011-05-06 2012-11-07 Lupin Limited Process for purification of cephalosporins
CN105622636B (zh) * 2016-02-05 2017-08-25 河南理工大学 一种头孢妥仑匹酯中间体的制备方法
CN113480491B (zh) * 2021-09-08 2022-05-06 山东昌邑四方医药化工有限公司 一种从头孢托仑母核生产废液中回收4-甲基噻唑-5-甲醛和三苯基氧膦的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
JPS6219593A (ja) 1985-07-18 1987-01-28 Meiji Seika Kaisha Ltd 新規セフエム化合物
JPH03128382A (ja) 1989-07-18 1991-05-31 Eisai Co Ltd チアゾリルアセトアミドセフェム系化合物
JPH06219593A (ja) * 1993-01-21 1994-08-09 Oki Electric Ind Co Ltd 電子写真記録装置
JP3128382B2 (ja) 1993-03-11 2001-01-29 旭 中野 鉄道車両運行支援表示装置
DE69427312T2 (de) 1993-11-17 2001-08-23 Biochemie Ges.M.B.H., Kundl Trennung von Cephalosporinisomeren
JPH0867684A (ja) * 1994-08-31 1996-03-12 Kyorin Pharmaceut Co Ltd 新規セフェム化合物、その製造法及び抗菌剤

Also Published As

Publication number Publication date
DE69807093T2 (de) 2003-03-27
IL133681A (en) 2003-10-31
AU7933198A (en) 1999-01-04
SK283525B6 (sk) 2003-09-11
WO1998058932A1 (en) 1998-12-30
CA2294178C (en) 2003-07-22
BR9810313A (pt) 2000-09-19
ES2182330T3 (es) 2003-03-01
AU731265B2 (en) 2001-03-29
KR100515273B1 (ko) 2005-09-15
PL193367B1 (pl) 2007-02-28
DE69807093D1 (de) 2002-09-12
EA200000065A1 (ru) 2000-08-28
HU228767B1 (en) 2013-05-28
CZ471899A3 (cs) 2000-07-12
EP1016665B1 (en) 2002-08-07
EP1016665A1 (en) 2000-07-05
NZ502234A (en) 2001-06-29
EP1016665A4 (en) 2001-06-13
CN1107679C (zh) 2003-05-07
CZ295599B6 (cs) 2005-08-17
ATE221890T1 (de) 2002-08-15
US6288223B1 (en) 2001-09-11
HUP0002458A3 (en) 2001-04-28
HUP0002458A2 (hu) 2001-02-28
BR9810313B1 (pt) 2010-11-30
KR20010014074A (ko) 2001-02-26
ID24210A (id) 2000-07-13
IL133681A0 (en) 2001-04-30
UA55463C2 (uk) 2003-04-15
CN1265662A (zh) 2000-09-06
JP3713282B2 (ja) 2005-11-09
CA2294178A1 (en) 1998-12-30
RO120261B1 (ro) 2005-11-30
PT1016665E (pt) 2002-12-31
PL339361A1 (en) 2000-12-18
EA002449B1 (ru) 2002-04-25
SK185799A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
TR200000310T2 (tr) Bir 3-(2-değiştirilmiş-vinil)-sefalosporin' in z-izomeri' nin seçici üretimine mahsus bir yöntem.
DE69715774D1 (de) 1-(2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosyl)-cytosine
BG106103A (bg) Лиганди на естрогеновия бета-рецептор
DE60022636D1 (de) Zink enthaltende zahnpasta zusammensetzungen
NO994662L (no) Fluorescerende hvitemidler
MX2008008298A (es) Sal de sulfato de hidrogeno novedosa.
MX2009010823A (es) Compuesto de hidrazida y agente controlador de artropodos dañinos que contiene el mismo.
GC0000087A (en) Quaternary phosphonium salt catalysts in catalytichydrolysis of alkylene oxides.
MX9604353A (es) Sistensis de cefalosporinas.
MY128709A (en) Phosphonites
DE60034849D1 (de) RGD-Sequenzen enthaltende peptido-mimetische Verbindungen als Integrin Inhibitioren
TW200643053A (en) Organoaluminum precursor compounds
DE60331586D1 (de) Festphase fluorierung von uracil
TW200745153A (en) Trehalose compound and pharmaceutical comprising the compound
MY161992A (en) Novel tetrahydroisoquinoline derivative
ATE260285T1 (de) Geschützte phenylalkylsilane
GB0317920D0 (en) Solid-phase synthesis
EP1718969B8 (en) An aqueous solution for use as medium for the specific binding reaction of a binding pair
BR9916254B1 (pt) processo para a preparação de alquileno glicóis.
AU4459300A (en) Anti-corrosion solutions for air dehumidification systems
MXPA00012863A (es) Proceso para la preparacion de 3-aril-benzofuranonas.
AU7413600A (en) Galvanizing solution for the galvanic deposition of copper
DK1163258T3 (da) Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
NO20075195L (no) En fremgangsmate for rensingen av 10-deacetylbaccatin III fra 10-deacetyl-2-deabenzoyl-2-pentenoylbaccatin III
MXPA03002937A (es) Benzimidazoles n-alcoxialquil-substituidos y su uso como agentes contra protozoos parasitantes.